Correlation Between Aquestive Therapeutics and Griffon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Griffon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Griffon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Griffon, you can compare the effects of market volatilities on Aquestive Therapeutics and Griffon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Griffon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Griffon.

Diversification Opportunities for Aquestive Therapeutics and Griffon

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Aquestive and Griffon is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Griffon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Griffon and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Griffon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Griffon has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Griffon go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Griffon

Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the Griffon. In addition to that, Aquestive Therapeutics is 1.0 times more volatile than Griffon. It trades about -0.05 of its total potential returns per unit of risk. Griffon is currently generating about 0.3 per unit of volatility. If you would invest  6,339  in Griffon on September 4, 2024 and sell it today you would earn a total of  1,927  from holding Griffon or generate 30.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aquestive Therapeutics  vs.  Griffon

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Aquestive Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Griffon 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Griffon are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Griffon reported solid returns over the last few months and may actually be approaching a breakup point.

Aquestive Therapeutics and Griffon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and Griffon

The main advantage of trading using opposite Aquestive Therapeutics and Griffon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Griffon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Griffon will offset losses from the drop in Griffon's long position.
The idea behind Aquestive Therapeutics and Griffon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes